A Fitchburg company based on research by a UW-Madison gerontologist has created three-dimensional tissue clusters derived from stem cells that can produce ovarian and testicular hormones.
We are sharing Wisconsin State Journal staffers' favorite work from 2019. From health reporter David Wahlberg: I spent much of this year doing…
UW-Madison researchers involved in two Madison-based stem cell companies have received a federal grant to test experimental therapies for heart failure in pigs.
The $21 million facility, next to the company's headquarters at University Research Park, will meet the Food and Drug Administration’s strict requirements for Good Manufacturing Practice. It will be at least 1,000 times cleaner than a regular lab, allowing production of cells for clinical trials.
Many doctors and ethicists worry that pro athletes - who have played a key role in popularizing stem cells - are misleading the public into thinking that the costly, controversial shots are an accepted, approved treatment.
A Shawano County resident is the first patient to get the procedure for scleroderma at UW, after a national study last year found it worked better than drugs.
Madison-area clinics are offering stem cell injections for joint pain, joining hundreds of clinics around the country promoting stem cell therapies for a variety of disorders — some of which federal regulators have tried to shut down, saying the treatments are unapproved and can be harmful.
We can get stem cells to produce particular types of cells. But how to replace an organ is still largely unknown.
Fujifilm Cellular Dynamics Inc.'s facility will be for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue.
When Brenda Quale donated a kidney to Barb Okey last month, she gave her something else: part of her immune system.
The stem cell discovery at UW-Madison in 1998 ushered in a new era of science. Today, researchers there continue their quest to find treatment…
Dr. David Gamm is one of about 100 faculty researchers using stem cells to model diseases, screen drugs or develop cell therapies at UW-Madison, where James Thomson gained international attention 20 years ago this month by announcing the world’s first isolation of human embryonic stem cells.
The first stem cell therapy developed at UW-Madison to enter a clinical trial was found to be safe and beneficial to patients, according to the company overseeing the treatment.
At UW-Madison, there are about 100 faculty researchers — and roughly 500 scientists overall — who are using stem cells for drug or chemical screening, disease modeling or developing cell therapies for disease.
It is possible to regenerate parts of the brain with stem cells, just like we can in other organs.
The stem cells, made by Cellular Dynamics International, are being studied on the International Space Station.
Anything scientists learn about regeneration by studying a relatively simple creature, like a planarian, can hold important clues.
The Wisconsin Assembly approved a measure on Thursday that would prohibit state health insurance programs from covering abortions for state workers.
In a step toward one of stem cell science’s chief goals, UW-Madison researchers have grown functional human artery cells that helped lab mice …